These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 32942031)

  • 21. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus.
    Katsiari CG; Liossis SN; Souliotis VL; Dimopoulos AM; Manoussakis MN; Sfikakis PP
    Clin Immunol; 2002 Apr; 103(1):54-62. PubMed ID: 11987985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
    Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
    J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis.
    Kwok SK; Tsokos GC
    Korean J Intern Med; 2018 Mar; 33(2):284-289. PubMed ID: 29320847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis.
    Jamaly S; Rakaee M; Abdi R; Tsokos GC; Fenton KA
    Autoimmun Rev; 2021 Dec; 20(12):102980. PubMed ID: 34718163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
    Koshy M; Berger D; Crow MK
    J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Wang M; Sun H; Zhang W; Zhang Y
    BMC Musculoskelet Disord; 2009 Nov; 10():141. PubMed ID: 19919693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
    Hara A; Furuichi K; Yamahana J; Yasuda H; Iwata Y; Sakai N; Shimizu M; Kaneko S; Wada T
    J Rheumatol; 2016 Jul; 43(7):1328-34. PubMed ID: 27134248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
    Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.
    Zhao LD; Liang D; Wu XN; Li Y; Niu JW; Zhou C; Wang L; Chen H; Zheng WJ; Fei YY; Tang FL; Li YZ; Zhang FC; He W; Cao XT; Zhang X
    Cell Mol Immunol; 2017 Oct; 14(10):842-849. PubMed ID: 27665947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
    Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
    Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
    Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
    Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
    Xiang L; Liu A; Xu G
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR4
    Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
    Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
    Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
    Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune podocytes in the immune microenvironment of lupus nephritis (Review).
    Liu R; Wen X; Peng X; Zhao M; Mi L; Lei J; Xu K
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.
    Ciferská H; Horák P; Hermanová Z; Ordeltová M; Zadrazil J; Tichý T; Scudla V
    Clin Rheumatol; 2007 May; 26(5):723-8. PubMed ID: 17103120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.
    Schwarting A; Relle M; Meineck M; Föhr B; Triantafyllias K; Weinmann A; Roth W; Weinmann-Menke J
    Lupus; 2018 Feb; 27(2):243-256. PubMed ID: 28659046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in systemic lupus erythematosus and lupus nephritis.
    Beckwith H; Lightstone L
    Nephron Clin Pract; 2014; 128(3-4):250-4. PubMed ID: 25471633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.